Rubin Lj - Search Results

1

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.

Galiè N, Rubin Lj, Hoeper M, Jansa P, Al-Hiti H, Meyer G, Chiossi E, Kusic-Pajic A, Simonneau G. Galiè N, et al. Among authors: rubin lj. Lancet. 2008 Jun 21;371(9630):2093-100. doi: 10.1016/S0140-6736(08)60919-8. Lancet. 2008. PMID: 18572079 Clinical Trial.

2

Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension.

Rich S, Rubin L, Walker AM, Schneeweiss S, Abenhaim L. Rich S, et al. Chest. 2000 Mar;117(3):870-4. doi: 10.1378/chest.117.3.870. Chest. 2000. PMID: 10713017

3

Cardiovascular effects of vasodilator therapy for pulmonary arterial hypertension.

Rubin LJ. Rubin LJ. Clin Chest Med. 1983 May;4(2):309-19. Clin Chest Med. 1983. PMID: 6342925 Review. No abstract available.

4

Calcium channel blockers in primary pulmonary hypertension.

Rubin LJ. Rubin LJ. Chest. 1985 Oct;88(4 Suppl):257S-260S. doi: 10.1378/chest.88.4_supplement.257s. Chest. 1985. PMID: 4042732

5

Therapy of secondary pulmonary hypertension.

Peil ML, Rubin LJ. Peil ML, et al. Among authors: rubin lj. Heart Lung. 1986 Sep;15(5):450-6. Heart Lung. 1986. PMID: 3639073

6

Risk stratification and treatment goals in pulmonary arterial hypertension.

Dardi F, Boucly A, Benza R, Frantz R, Mercurio V, Olschewski H, Rådegran G, Rubin LJ, Hoeper MM. Dardi F, et al. Among authors: rubin lj. Eur Respir J. 2024 Oct 31;64(4):2401323. doi: 10.1183/13993003.01323-2024. Print 2024 Oct. Eur Respir J. 2024. PMID: 39209472 Free PMC article. Review.

7

The Seventh World Symposium on Pulmonary Hypertension: our journey to Barcelona.

Humbert M, Galiè N, Rubin LJ, Simonneau G, McLaughlin VV. Humbert M, et al. Among authors: rubin lj. Eur Respir J. 2024 Oct 31;64(4):2401222. doi: 10.1183/13993003.01222-2024. Print 2024 Oct. Eur Respir J. 2024. PMID: 39209470 Free PMC article.

8

Is There a Role for Calcium Channel Blockers in the Contemporary Treatment Paradigm for Pulmonary Arterial Hypertension?

Rubin LJ. Rubin LJ. Circulation. 2024 May 14;149(20):1565-1567. doi: 10.1161/CIRCULATIONAHA.124.069124. Epub 2024 May 13. Circulation. 2024. PMID: 38739700 No abstract available.

9

Sotatercept for pulmonary arterial hypertension: something old and something new.

Rubin LJ, Naeije R. Rubin LJ, et al. Eur Respir J. 2023 Jan 6;61(1):2201972. doi: 10.1183/13993003.01972-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36609525 Free article. No abstract available.

10

Using a knowledge translation program to facilitate guideline- and evidence-based patient management: the PAH-QuERI Extension Program.

McLaughlin VV, Channick RN, Lynum KSB, Oudiz RJ, Selej M, Tapson VF, Rubin LJ. McLaughlin VV, et al. Among authors: rubin lj. Pulm Circ. 2022 Jul 1;12(3):e12134. doi: 10.1002/pul2.12134. eCollection 2022 Jul. Pulm Circ. 2022. PMID: 36172596 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters